Ilaris (Canakinumab) in the Schnitzler Syndrome
Condition(s):Schnitzler SyndromeLast Updated:July 5, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Schnitzler SyndromeLast Updated:July 5, 2019Completed
Condition(s):Schnitzler SyndromeLast Updated:July 17, 2018Completed
Condition(s):Schnitzler SyndromeLast Updated:September 8, 2017Completed
Condition(s):Schnitzler SyndromeLast Updated:February 2, 2024Terminated
Condition(s):Schnitzler’s SyndromeLast Updated:February 17, 2020Completed
Condition(s):Schnitzler SyndromeLast Updated:May 24, 2012Completed
Condition(s):Schnitzler Syndrome; Urticarial Vasculitis With Monoclonal Immunoglobulin M Component, Schnitzler (Disorder)Last Updated:December 22, 2022Not yet recruiting
Condition(s):Muckle-Wells Syndrome; Schnitzler SyndromeLast Updated:May 31, 2012Completed
Condition(s):Autoinflammatory Syndromes; HIDS; TRAPS; Schnitzler’s SyndromeLast Updated:March 1, 2007Unknown status
Condition(s):Hereditary Autoinflammatory Diseases; Schnitzler Syndrome; Behcet Syndrome; PFAPA Syndrome; Still Disease; Autoinflammatory Syndrome, Unspecified; Uveitis; Scleritis; Vexas SyndromeLast Updated:February 21, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.